BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng HL, Chen D, Yan J, Yang Q, Han QQ, Li SS, Cheng L. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. FEBS J 2021;288:5190-200. [PMID: 33098359 DOI: 10.1111/febs.15609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Meijer MT, de Vos AF, Peters Sengers H, Scicluna BP, Roelofs JJ, Abou Fayçal C, Uhel F, Orend G, van der Poll T. Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in Mice. Microbiol Spectr 2021;9:e0020721. [PMID: 34319124 DOI: 10.1128/Spectrum.00207-21] [Reference Citation Analysis]
2 Xu S, Zhang T, Cao Z, Zhong W, Zhang C, Li H, Song J. Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights. Front Immunol 2021;12:638400. [PMID: 33790909 DOI: 10.3389/fimmu.2021.638400] [Reference Citation Analysis]
3 Almuntashiri S, James C, Wang X, Siddiqui B, Zhang D. The Potential of Lung Epithelium Specific Proteins as Biomarkers for COVID-19-Associated Lung Injury. Diagnostics (Basel) 2021;11:1643. [PMID: 34573984 DOI: 10.3390/diagnostics11091643] [Reference Citation Analysis]
4 Suresh V, Mohanty V, Avula K, Ghosh A, Singh B, Reddy RK, Parida D, Suryawanshi AR, Raghav SK, Chattopadhyay S, Prasad P, Swain RK, Dash R, Parida A, Syed GH, Senapati S. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity. FASEB J 2021;35:e21713. [PMID: 34105201 DOI: 10.1096/fj.202100431R] [Reference Citation Analysis]
5 Chiappalupi S, Salvadori L, Donato R, Riuzzi F, Sorci G. Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk. Biomolecules 2021;11:876. [PMID: 34204735 DOI: 10.3390/biom11060876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021;12:4869. [PMID: 34381043 DOI: 10.1038/s41467-021-25030-7] [Reference Citation Analysis]
7 Dhaouadi S, Ben Abderrazek R, Loustau T, Abou-Faycal C, Ksouri A, Erne W, Murdamoothoo D, Mörgelin M, Kungl A, Jung A, Ledrappier S, Benlasfar Z, Bichet S, Chiquet-Ehrismann R, Hendaoui I, Orend G, Bouhaouala-Zahar B. Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. Front Immunol 2021;12:635166. [PMID: 33790905 DOI: 10.3389/fimmu.2021.635166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aschenbrenner AC, Mouktaroudi M, Krämer B, Oestreich M, Antonakos N, Nuesch-Germano M, Gkizeli K, Bonaguro L, Reusch N, Baßler K, Saridaki M, Knoll R, Pecht T, Kapellos TS, Doulou S, Kröger C, Herbert M, Holsten L, Horne A, Gemünd ID, Rovina N, Agrawal S, Dahm K, van Uelft M, Drews A, Lenkeit L, Bruse N, Gerretsen J, Gierlich J, Becker M, Händler K, Kraut M, Theis H, Mengiste S, De Domenico E, Schulte-Schrepping J, Seep L, Raabe J, Hoffmeister C, ToVinh M, Keitel V, Rieke G, Talevi V, Skowasch D, Aziz NA, Pickkers P, van de Veerdonk FL, Netea MG, Schultze JL, Kox M, Breteler MMB, Nattermann J, Koutsoukou A, Giamarellos-Bourboulis EJ, Ulas T; German COVID-19 Omics Initiative (DeCOI). Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med 2021;13:7. [PMID: 33441124 DOI: 10.1186/s13073-020-00823-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 25.0] [Reference Citation Analysis]
9 Zacchigna S, Marcello A, Banks L. Spotlight on COVID-19: eighteen months on. FEBS J 2021;288:4992-5. [PMID: 34490732 DOI: 10.1111/febs.16167] [Reference Citation Analysis]
10 Tan HW, Xu YM, Lau ATY. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications. Expert Rev Proteomics 2021;18:925-38. [PMID: 34812694 DOI: 10.1080/14789450.2021.2010549] [Reference Citation Analysis]
11 MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, Paglionico A, Petricca L, Bosello SL, Carfì A, Sali M, Stigliano E, Cingolani A, Murri R, Arena V, Fantoni M, Antonelli M, Landi F, Franceschi F, Sanguinetti M, McInnes IB, McSharry C, Gasbarrini A, Otto TD, Kurowska-Stolarska M, Gremese E. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight 2021;6:147413. [PMID: 34143756 DOI: 10.1172/jci.insight.147413] [Reference Citation Analysis]
12 Rajczewski AT, Mehta S, Nguyen DDA, Grüning B, Johnson JE, McGowan T, Griffin TJ, Jagtap PD. A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19). Clin Proteomics 2021;18:15. [PMID: 33971807 DOI: 10.1186/s12014-021-09321-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen T, Polak P, Uryasev S. Classification and severity progression measure of COVID-19 patients using pairs of multi-omic factors. Journal of Applied Statistics. [DOI: 10.1080/02664763.2022.2064975] [Reference Citation Analysis]
14 Rajczewski AT, Mehta S, Nguyen DDA, Grüning BA, Johnson JE, McGowan T, Griffin TJ, Jagtap PD. A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19). medRxiv 2021:2021. [PMID: 33688669 DOI: 10.1101/2021.02.09.21251427] [Reference Citation Analysis]
15 Luo Z, Zhu C, Ruan Z, Cui X, Shereen MA, Pan P, Huang J, Wang F, Su H, Xia Y, Wu J. Longitudinal Characterization of Cytokine Overproduction: A Case Report in Critically Ill COVID-19 Patients With Hyperinflammation in Bronchoalveolar Lavage. Front Med (Lausanne) 2021;8:690523. [PMID: 34557500 DOI: 10.3389/fmed.2021.690523] [Reference Citation Analysis]
16 Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, Crea F, Kaski JC, Tousoulis D. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci 2021;22:6607. [PMID: 34205487 DOI: 10.3390/ijms22126607] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Feng Y, Tang K, Lai Q, Liang J, Feng M, Zhou Z, Cui H, Du X, Zhang H, Sun L. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Physiol 2022;12:818297. [DOI: 10.3389/fphys.2021.818297] [Reference Citation Analysis]
18 Cabalak M, Doğan S, Bal T, Dikmen N. Serum periostin levels in COVID-19: Is it useful as a new biomarker? Int J Clin Pract 2021;:e14728. [PMID: 34396648 DOI: 10.1111/ijcp.14728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zhong L, Zhu L, Cai ZW. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review. J Anal Test 2021;:1-16. [PMID: 34513131 DOI: 10.1007/s41664-021-00197-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Biji A, Khatun O, Swaraj S, Narayan R, Rajmani RS, Sardar R, Satish D, Mehta S, Bindhu H, Jeevan M, Saini DK, Singh A, Gupta D, Tripathi S. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. EBioMedicine 2021;70:103525. [PMID: 34392148 DOI: 10.1016/j.ebiom.2021.103525] [Reference Citation Analysis]